Despite 2023 seeing the highest premium increase in over a decade, the price of Switzerland’s compulsory insurance is likely to rise again in 2024. Swiss operators tell HBI they aren’t getting help to deal with inflation.
Archives
Mubadala-backed M42 buying Diaverum “for $2bn+”
Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion.
April 19, 2023
How will AI change healthcare services?
Healthcare services companies and public health systems are looking at ways they can integrate AI into their workflows. What will the future of healthcare services look like? HBI speaks to digital health experts to find out more.
April 19, 2023
More UK outsourcing on the way, and NHS crisis here to stay as doctors look abroad
The government taskforce setting out how the UK NHS will outsource more to tackle its record-breaking backlog is set to be published soon. However while the private sector is willing to help, other long-term issues like workforce and capacity mean public sector issues will persist. HBI speaks to UK healthcare sources to find out more.
April 14, 2023
Practice Plus Group launches affordable self-pay offering
UK hospital operator Practice Plus Group has launched a middle-market option for self-pay at a time when the segment is growing.
April 14, 2023
Medica results show familiar state of UK healthcare services
Medica, which provides teleradiology services to the UK NHS, operates in Ireland, and has a presence in the US, has released its latest financial results. The company is continuing to grow, but feeling the pinch from inflationary pressures.
April 14, 2023
Spanish insurer for doctors sees profit boost
A Spanish mutual insurance company which caters specifically to doctors saw its profits and uptake rise as the global health workforce crisis shows no signs of abating.
April 14, 2023
Diaverum deal: An analysis
Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.
April 6, 2023
Mediclinic acquisition conditional on “hidden tax” pro-bono surgery and training spend
South Africa’s competition tribunal have officially approved the acquisition of South Africa-based multinational hospital group Mediclinic, but the buyers needed to accept conditions which were less to do with competition, and more to do with the public good.
April 5, 2023
UAE sovereign wealth fund “targets $2.5bn Diaverum”
Abu Dhabi sovereign wealth fund Mubadala Investment Co is considering the acquisition of $2.5bn Swedish pan-European dialysis group Diaverum, according to reports.
March 31, 2023
FREE BLOG Is the deals dam ready to burst?
Economic uncertainty and a slew of global problems led to an M&A slowdown at the end of last year, and into 2023. Could we see a flood of deals in Q2?
March 31, 2023
Icade reaches agreement to sell healthcare real estate to Primonial REIM
French real estate investment trust Icade has signed an exclusivity agreement on the sale of its minority stake in Icade Santé, part of its healthcare real estate portfolio, to France-based pan-European real estate investment firm Primonial REIM, and is arranging the sale of the asset portfolio owned by Icade Healthcare Europe (IHE).
